Per USPTO, Goods and Services (IC 038. 100 101 104. G & S)
Communication services, namely, providing electronic transmission of information stored in a database via interactively communicating computer systems. FIRST USE: 20200115. FIRST USE IN COMMERCE: 20200115
What inspired us?
The lack of automation, communication, and standardization; with regards to electronic PHI (Protected Health Information) data transfer in Healthcare. Therefore, we created a secure cloud-based application which is easily accessible by smartphone, pad, laptop or desktop computer. Our target users are healthcare providers and stakeholders, patients, and researchers. Access will always be free for patients. Plus, healthcare providers and stakeholders will realize a 50 to 80% cost savings, based on their current health information exchange (HIE) vendor.
What does it do?
GenOp Software agnostically transfers comprehensive patient encounter data from one EHR/EMR (Electronic Health/Medical Record) system to another. The information will include a COVID-19 Flag, with the patient's consent. This satisfies the continuity of care aspect, during the admission-discharge-transfer (ADT) protocol. As a process, this workflow will pro-actively alert receiving Healthcare Providers, allowing them the life-saving opportunity to don their Personal Protective Equipment (PPE), exercise precautions, and apply isolation measures. Therefore, mitigating the spread of this novel Coronavirus. Our app also works synergistically and in tandem with Tele-Medicine/Tele-Health, to encourage social and physical distancing, quarantining, "stay at home" or "shelter in place" orders; whenever and wherever appropriate. This Web Application Cloud Software integrates and incorporates Hospitals, Doctor's Offices, Outpatient Health and Imaging Facilities, Pharmacies, Ambulance companies, Laboratories, Home Health Agencies, Health Insurance Companies, and Government Entities; into one big ## Healthcare Data Ecosystem ##. Thus, promoting interoperability. In fact, gone will be the days of having to fill out paper forms and documents. Patient Access and Authorization will be completely electronic and digital. Let's not forget that the COVID-19 virus lives on surfaces (like pens, pencils, paper, clipboards, waiting room seats, etc...), for up to three days! Our program will "flatten the curve", and it will not matter if a patient is symptomatic, asymptomatic, infected or not. This pandemic is the worst many of us may have experienced in our lifetime. The devastation to the world's people, and the global economy, is unfathomable. Unfortunately, this will not be the last!
How we built it?
Owing to the wide acceptance of HL7's FHIR API, our application sprouted from the delivery of the aforementioned standard.
Challenges we ran into?
## Funding ##. We would like to create a comprehensive and universal patient portal. In addition, we would also love to build an analytics suite, and apportion Artificial Intelligence plus Machine Learning, to "contact tracing". But, the cost of storing all that data is quite expensive. ## Information Blocking ##. To all of the healthcare enterprises and EHR/EMR vendors, who practice the aforementioned (You know who you are.), please know that patients own their health data; and they can do with it as they please.
Accomplishments that we're proud of?
In December 2019, our team developed a demo app/prototype/proof of concept that transfers PHI in a secure and HIPAA-compliant manner.
What we learned?
It is very important to obtain permission from the patients, because they own their data after all. It is uplifting to see, that with GenOp, patients are more empowered than ever to participate in their healthcare. Also, the human brain is wired to assimilate events and digest information; in a structured, chronological format. Therefore, our team made sure that the patients' encounters are electronically transcribed, and arranged from newest to oldest, on the receiving EHR/EMR.
What's next for GenOp?
Seeing a working, production-ready GenOp program; being used locally, domestically; then internationally.